Wave Life Sciences (WVE) Asset Utilization Ratio (2015 - 2026)

Wave Life Sciences (WVE) has 12 years of Asset Utilization Ratio data on file, last reported at 0.1 in Q2 2026.

• Quarterly Asset Utilization Ratio fell 44.82% year-over-year to 0.1 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.1 (down 44.82% YoY) and the FY2025 annual result came in at 0.09, down 75.03% from the prior year.
• Asset Utilization Ratio retreated to 0.1 in Q2 2026, from 0.12 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.5 in Q2 2024 to a low of 0.02 in Q3 2022.
• A 5-year average of 0.22 and a median of 0.2 in 2025 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio plunged 91.15% — and 2023, when it soared 2044.08%.
• Tracing WVE's Asset Utilization Ratio over 5 years: stood at 0.02 in 2022, then soared by 2044.08% to 0.48 in 2023, then increased by 4.28% to 0.5 in 2024, then slumped by 62.76% to 0.19 in 2025, then tumbled by 44.82% to 0.1 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.1 (Q2 2026), 0.12 (Q1 2026), and 0.19 (Q2 2025), per Business Quant data.